At CEDAR, Duygu Altinok Dindar is wishing to participate in translational research studies as well as precision medicine projects. Her final goal is to initiate international collaborations to identify novel biomarkers for early cancer detection. She was part of translational research teams composed of several biotech startups and universities in Turkey. She is also a delegate of International Consortium of Personalised Medicine (IcPermed) and a member of NCI Alumni Global Cancer Research Collaborative Team. Duygu wants to bring in her motivation and her skills to facilitate and accelerate CEDAR research projects so that to increase the impact of their findings can be expedited from the research world to the community. Duygu is also interested in multidisciplinary data analyses.